Practical Aspects of Allogeneic Hematopoietic Cell Transplantation for Patients with Poor-Risk Chronic Lymphocytic Leukemia

被引:1
|
作者
Delgado, Julio [1 ]
Duarte, Rafael F. [2 ]
机构
[1] Hosp Santa Creu & Sant Pau, Dept Hematol, Barcelona, Spain
[2] ICO Hosp Duran & Reynals, Dept Hematol, Barcelona, Spain
来源
THESCIENTIFICWORLDJOURNAL | 2011年 / 11卷
关键词
chronic lymphocytic leukemia; allogeneic hematopoietic cell transplantation; MINIMAL RESIDUAL DISEASE; CONDITIONING REGIMENS; ALEMTUZUMAB; FLUDARABINE; LYMPHOMA; RITUXIMAB; THERAPY; SIROLIMUS; SURVIVAL; BLOOD;
D O I
10.1100/tsw.2011.21
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Allogeneic hematopoietic cell transplantation has become a viable option for younger patients with poor-risk chronic lymphocytic leukemia. The results obtained with either conventional or reduced-intensity conditioning regimens have been recently evaluated and compared with alternative nontransplant strategies. This manuscript deals with practical aspects of the procedure, including patient and donor selection, conditioning regimen, GVHD prophylaxis, disease monitoring, infectious and noninfectious complications, and timing of the procedure. Finally, we speculate on how we could improve the results obtained with the procedure and new advances currently in clinical trials.
引用
收藏
页码:161 / 172
页数:12
相关论文
共 50 条
  • [1] Fludarabine with cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with poor-risk chronic lymphocytic leukemia
    Marta Krejci
    Michael Doubek
    Yvona Brychtova
    Olga Stehlikova
    Jana Chovancova
    Boris Tichy
    Hana Skuhrova Francova
    Milan Navratil
    Miroslav Tomiska
    Ondrej Horky
    Sarka Pospisilova
    Jiri Mayer
    [J]. Annals of Hematology, 2013, 92 : 249 - 254
  • [2] Fludarabine with cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with poor-risk chronic lymphocytic leukemia
    Krejci, Marta
    Doubek, Michael
    Brychtova, Yvona
    Stehlikova, Olga
    Chovancova, Jana
    Tichy, Boris
    Francova, Hana Skuhrova
    Navratil, Milan
    Tomiska, Miroslav
    Horky, Ondrej
    Pospisilova, Sarka
    Mayer, Jiri
    [J]. ANNALS OF HEMATOLOGY, 2013, 92 (02) : 249 - 254
  • [3] Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia
    Gribben, JG
    Zahrieh, D
    Stephans, K
    Bartlett-Pandite, L
    Alyea, EP
    Fisher, DC
    Freedman, AS
    Mauch, P
    Schlossman, R
    Sequist, LV
    Soiffer, RJ
    Marshall, B
    Neuberg, D
    Ritz, J
    Nadler, LM
    [J]. BLOOD, 2005, 106 (13) : 4389 - 4396
  • [4] Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia
    Michallet, Mauricette
    Sobh, Mohamad
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S19 - S20
  • [5] Progressive Chronic Lymphocytic Leukemia After Allogeneic Hematopoietic Cell Transplantation
    Jitawatanarat, Potjana
    Desai, Arpita
    Sharda, Pradeep
    Liu, Hong
    Ross, Maureen
    Hernandez-Llizaliturri, Francisco J.
    McCarthy, Philip L.
    Chen, George L.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 (10): : 1203 - 1206
  • [6] The role of allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: A review
    Puckrin, Robert
    Shafey, Mona
    Storek, Jan
    [J]. FRONTIERS IN ONCOLOGY, 2023, 12
  • [7] Allogeneic stem cell transplantation for poor-risk chronic lymphocytic leukemia using reduced-intensity conditioning: interim results of a prospective study
    Dreger, P
    Stilgenbauer, S
    Bunjes, D
    Humpe, A
    Ritgen, M
    Seyfarth, B
    Truemper, L
    Kneba, M
    Schmitz, N
    Doehner, H
    [J]. BONE MARROW TRANSPLANTATION, 2003, 31 : S56 - S56
  • [8] Paradigm shifts in the management of poor-risk chronic lymphocytic leukemia
    Innis-Shelton, Racquel D.
    Davis, Randall S.
    Lamb, Lawrence
    Mineishi, Shin
    [J]. LEUKEMIA & LYMPHOMA, 2015, 56 (06) : 1626 - 1635
  • [9] Allogeneic hematopoietic stem cell transplantation with nonmyeloablative conditioning for patients with chronic lymphocytic leukemia.
    Flowers, CR
    Maloney, DG
    Sandmaier, BM
    Shizuru, JA
    McSweeney, PA
    Chauncey, TR
    Niederwieser, D
    Sahebi, F
    Agura, E
    Blume, K
    Forman, S
    Storb, R
    [J]. BLOOD, 2001, 98 (11) : 418A - 418A
  • [10] OUTCOMES AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH ADVANCED CHRONIC LYMPHOCYTIC LEUKEMIA
    Rashed, A.
    Corringham, S.
    Castro, J. E.
    Kipps, T. J.
    Ball, E. D.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S295 - S295